NEPHROS INC — Form SCHEDULE 13D/A
Filed September 16, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A
— Neutral
significance 18/100
What the filing says
Wexford Capital LP filed an amended Schedule 13D/A regarding its beneficial ownership in Nephros Inc (market value ~$27.3M) on September 16, 2026. The filing document itself contains no specific details about share counts, percentages, dollar amounts, or what changed from the original filing. The amendment was accepted the same day but the substantive changes or current ownership position are not disclosed in the available filing header information.
Why this rating
Amendment lacks disclosed specifics; without details on ownership stake size or changes, cannot assess materiality independently.
See more from September 16, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.